What is Clinuvel Pharmaceuticals Limited (CUV) Stock Price?
The live share price and session change for Clinuvel Pharmaceuticals Limited (CUV) are shown in the TradingView quote on this page.
CUV Stock Price, Valuation & Chart | Clinuvel Pharmaceuticals Limited
CUV Historical price chart
CUV Key Stats
Fair Value
Disclaimer
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Market Capitalization418.91M
PE Ratio12.15
EPS0.68
Trading Volume120.51K
Today's High/Low8.33/8.03
Dividend Yield0.50
52 Week High/Low13.48/7.93
Shares Outstanding50.41M
CUV Financial Statement
CUV Analyst ratings
Buy
Strong buy
1
Buy
7
Hold
0
Sell
0
Strong sell
0
Based on 8 analysts giving stock ratings to CUV in the past 3 months.
CUV Analysis & performance metrics
CUV Company profile
Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening…
CUV Management team
Name
Position
Peter VaughanCFO
Chief Financial Officer
Claire Newstead-Sinclair C.A.
Company Secretary
Dennis J. Wright BPharm, M.Sc., Ph.D.
Chief Scientific Officer
Rose Quadbeck-Diel
Senior Vice President of Regulatory Affairs
Azza Hamila
Head of Quality Assurance & Drug Safety
Philippe Jacques Wolgen M.B.A., M.D.CEO
Chief Executive Officer, MD & Director
Lachlan Hay
Chief Operations Officer
Malcolm Bull
Head of Australian Operations & Investor Relations
Name
Position
Peter VaughanCFO
Chief Financial Officer
Claire Newstead-Sinclair C.A.
Company Secretary
Dennis J. Wright BPharm, M.Sc., Ph.D.
Chief Scientific Officer
Rose Quadbeck-Diel
Senior Vice President of Regulatory Affairs
Azza Hamila
Head of Quality Assurance & Drug Safety
Philippe Jacques Wolgen M.B.A., M.D.CEO
Chief Executive Officer, MD & Director
Lachlan Hay
Chief Operations Officer
Malcolm Bull
Head of Australian Operations & Investor Relations
Management Team
Peter VaughanCFO
Chief Financial Officer
Claire Newstead-Sinclair C.A.
Company Secretary
Dennis J. Wright BPharm, M.Sc., Ph.D.
Chief Scientific Officer
Rose Quadbeck-Diel
Senior Vice President of Regulatory Affairs
Azza Hamila
Head of Quality Assurance & Drug Safety
Philippe Jacques Wolgen M.B.A., M.D.CEO
Chief Executive Officer, MD & Director
Lachlan Hay
Chief Operations Officer
Malcolm Bull
Head of Australian Operations & Investor Relations
Management
Peter VaughanCFO
Chief Financial Officer
Claire Newstead-Sinclair C.A.
Company Secretary
Dennis J. Wright BPharm, M.Sc., Ph.D.
Chief Scientific Officer
Rose Quadbeck-Diel
Senior Vice President of Regulatory Affairs
Azza Hamila
Head of Quality Assurance & Drug Safety
Philippe Jacques Wolgen M.B.A., M.D.CEO
Chief Executive Officer, MD & Director
Lachlan Hay
Chief Operations Officer
Malcolm Bull
Head of Australian Operations & Investor Relations
Total 8 executives
CUV Frequently asked questions
Why is the Clinuvel Pharmaceuticals Limited (CUV) stock price going up or down today?
The stock price of Clinuvel Pharmaceuticals Limited (CUV) can change with earnings, company news, and overall market sentiment. Clinuvel Pharmaceuticals Limited operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live TradingView quote on this page together with the chart and key stats.
Is the Clinuvel Pharmaceuticals Limited stock expensive at its current price?
Whether Clinuvel Pharmaceuticals Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CUV on this page is 12.15. EPS on this page is 0.68. Compare those figures with peers and growth expectations before deciding if the current Clinuvel Pharmaceuticals Limited price is justified.
How has the stock price of Clinuvel Pharmaceuticals Limited (CUV) performed historically?
Historical performance for Clinuvel Pharmaceuticals Limited (CUV) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CUV reacted to past earnings and market events.
Should I buy Clinuvel Pharmaceuticals Limited (CUV) stock, at this price?
Buying Clinuvel Pharmaceuticals Limited (CUV) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.